Aeluma (ALMU) director awarded 13,343 RSUs and 3,653 stock options

Rhea-AI Filing Summary

Aeluma, Inc. director Byron Michael reported receiving equity-based compensation in the form of common stock and stock options. He was granted 13,343 shares of common stock as restricted stock units that are scheduled to vest over several dates through November 30, 2026. The vesting schedule covers approximately 1/12 of the shares on December 31, 2025, 1/4 of the shares on March 31, June 30, and September 30, 2026, and 1/6 of the shares on November 30, 2026. He also acquired stock options for 3,653 shares that are fully vested as of the grant, giving him the right to buy additional common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Byron Michael

(Last) (First) (Middle)

27 CASTILIAN DRIVE

(Street)

GOLETA CA 93117

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aeluma, Inc. [ ALMU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/03/2025		A		13,343(1)	A	$0	13,343	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$18.27	09/01/2025		A		3,653		(2)	09/01/2035	Common Stock	3,653	$0	3,653	D

Explanation of Responses:

1. Restricted stock units scheduled to vest with respect to approximately 1/12 of the shares on December 31, 2025, 1/4 of the shares on March 31, June 30, and September 30, 2026, and 1/6 of the shares on November 30, 2026.

2. Fully vested.

	/s/ Joshua L. Colburn, Attorney-in-Fact	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Aeluma (ALMU) director Byron Michael report in this Form 4?

Byron Michael reported receiving equity compensation in Aeluma common stock and stock options. He was granted 13,343 restricted stock units and 3,653 fully vested stock options, reflecting non-cash awards rather than open-market share purchases or sales.

How many Aeluma (ALMU) shares did Byron Michael acquire as restricted stock units?

Byron Michael was granted 13,343 shares of Aeluma common stock as restricted stock units. These units represent future share deliveries that vest over time, subject to the detailed vesting schedule disclosed in the filing’s footnote.

What is the vesting schedule for Byron Michael’s Aeluma (ALMU) restricted stock units?

The restricted stock units vest approximately 1/12 on December 31, 2025, 1/4 on March 31, June 30, and September 30, 2026, and 1/6 on November 30, 2026. This structure staggers share delivery across multiple future dates.

What stock options did Byron Michael receive from Aeluma (ALMU)?

He received stock options covering 3,653 shares of Aeluma common stock. The filing notes these options are fully vested, meaning they are immediately exercisable, subject to their terms, and were acquired as part of an award, not via market purchase.

Were Byron Michael’s Aeluma (ALMU) equity awards open-market transactions?

No. Both transactions are coded as grants or awards. The Form 4 describes a grant of restricted stock units and a fully vested stock option award, rather than open-market buying or selling of Aeluma shares.